The March 2014 Monthly Data Updates includes:
Additions to the PBS:
- Aldiq (imiquimod) Aspen Pharma (10c)
5% 250 mg (single use sachet) [12]: Authority - PBS/RPBS - Auro-Lisinopril (lisinopril) Aurobindo Pharma (2a)
5 mg [30]: PBS/RPBS (NP)
10 mg [30]: PBS/RPBS (NP)
20 mg [30]: PBS/RPBS (NP) - Azastrole (anastrozole) Eris (9e)
1 mg [30]: Restricted - PBS/RPBS (NP) - basecal 100 (multiple actives) Vitaflo (19b)
21.5 g [30] x 4: Restricted - PBS/RPBS (NP) - basecal 200 (multiple actives) Vitaflo (19b)
43 g [30] x 4: Restricted - PBS/RPBS (NP) - betaquik (triglycerides, medium chain) Vitaflo (19b)
250 mL (carton) [18] x 2: Authority - PBS/RPBS (NP) - Bicalox (bicalutamide) Eris (9e)
50 mg [28]: Authority (Streamlined) - PBS/RPBS (NP) - Bicalutamide-GA (bicalutamide) Ascent Pharma (9e)
50 mg [28]: Authority (Streamlined) - PBS/RPBS (NP) - carbzero (triglycerides, long chain) Vitaflo (19b)
250 mL (carton) [18] x 2: Restricted - PBS/RPBS (NP) - Clavam (amoxycillin; clavulanic acid) Norac Pharma (8a)
875 mg/125 mg [10]: Restricted - PBS/RPBS (NP) - docomega (docosahexaenoic acid; carbohydrate) Vitaflo (19b)
4 g [30] x 4: Authority - PBS/RPBS (NP) - keyomega (multiple actives) Vitaflo (19b)
4 g [30] x 4: Authority - PBS/RPBS (NP) - Kombiglyze XR 2.5 mg/1000 mg tablets (saxagliptin; metformin hydrochloride) Bristol-Myers Squibb (6e)
2.5 mg/1000 mg [56]: Authority (Streamlined) - PBS/RPBS (NP)
5 mg/500 mg [28]: Authority (Streamlined) - PBS/RPBS (NP)
5 mg/1000 mg [28]: Authority (Streamlined) - PBS/RPBS (NP) - Lumigan PF (bimatoprost) Allergan (14c)
0.03% 0.4 mL [30]: PBS/RPBS - Rispernia (risperidone) Eris (3c)
0.5 mg [60]: Authority (Streamlined) - PBS/RPBS (NP)
1 mg [60]: Authority (Streamlined) - PBS/RPBS (NP)
2 mg [60]: Authority (Streamlined) - PBS/RPBS (NP)
3 mg [60]: Authority (Streamlined) - PBS/RPBS (NP)
4 mg [60]: Authority (Streamlined) - PBS/RPBS (NP) - Sertraline Actavis (sertraline) Actavis (3d)
50 mg [30]: Restricted - PBS/RPBS (NP)
100 mg [30]: Restricted - PBS/RPBS (NP) - Temozolomide Alphapharm (temozolomide) Alphapharm (9a)
5 mg [5] x 3: Authority - PBS/RPBS
20 mg [5] x 3: Authority - PBS/RPBS
100 mg [5] x 3: Authority - PBS/RPBS
140 mg [5] x 3: Authority - PBS/RPBS
250 mg [5]: Authority - PBS/RPBS
Topra (pantoprazole) Aurobindo Pharma (1a)
40 mg [30]: Restricted - PBS/RPBS (NP) - Torzole (pantoprazole) Actavis (1a)
40 mg [30]: Restricted - PBS/RPBS (NP) - Trajentamet 2.5 mg/500 mg Tablets (linagliptin; metformin hydrochloride) Boehringer Ingelheim (6e)
2.5 mg/500 mg [60]: Authority (Streamlined) - PBS/RPBS (NP) - Trajentamet 2.5 mg/850 mg Tablets (linagliptin; metformin hydrochloride) Boehringer Ingelheim (6e)
2.5 mg/850 mg [60]: Authority (Streamlined) - PBS/RPBS (NP) - Trajentamet 2.5 mg/1000 mg Tablets (linagliptin; metformin hydrochloride) Boehringer Ingelheim (6e)
2.5 mg/1000 mg [60]: Authority (Streamlined) - PBS/RPBS (NP) - Votrient (pazopanib) GlaxoSmithKline Australia (9f)
200 mg [90]: Authority - PBS/RPBS
400 mg [30]: Authority - PBS/RPBS
Restriction changes:
- Botox (botulinum toxin type a) Allergan (5f)
100 U (solv. needed) [1]: Section 100 - Botulinum Toxin Program - Energivit (multiple actives) Nutricia (19b)
400 g [1] x 8: Restricted - PBS/RPBS (NP)
the latest MIMS Medicine Information
- Over 160 updates or additions to the MIMS listings
New listings include:
- APO-Metoclopramide (metoclopramide hydrochloride) Apotex (3h)
- Ellura (vaccinium macrocarpon juice powder) Flordis (22i)
- Madeline (desogestrel; ethinyloestradiol) Apotex (18a)
- Optive Advanced (multiple actives) Allergan (14f)
- Sertraline Actavis (sertraline) Actavis (3d)
- Sodium Bicarbonate 8.4% Injection (8.4 g/100 mL) (sodium bicarbonate) Phebra (19d)
- Tivicay (dolutegravir) ViiV (8i)
the latest MIMS DrugAlert data
the latest CMIs
- Over 60 updates or additions to the collection
